文献速递白血病

急性髓系白血病严格与非严格完全缓解及其预后:一项丹麦人群研究

Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia: a Danish population-based study.
PubMed 文献 · Blood Adv · 2018-01-01

该丹麦全国急性白血病登记研究纳入769例诱导后骨髓原始细胞<5%的经典完全缓解患者,依据全国实验室与输血数据库分为严格完全缓解(sCR,n=360,46.8%)和非严格完全缓解(non-sCR,n=409,53.2%)。校正协变量后,sCR患者的总生存(HR 1.34;95%CI 1.10-1.64)和无复发生存(HR 1.25;95%CI 1.03-1.51)均优于non-sCR患者,且三个系恢复标准均为独立预后因素。

要点

  • 经典完全缓解患者中,sCR占46.8%,non-sCR占53.2%。
  • 校正后sCR患者总生存优于non-sCR(HR 1.34;95%CI 1.10-1.64)。
  • 三个系恢复标准均为独立预后因素,支持国际缓解评价标准。

核心结论

  • 该真实世界登记研究支持国际缓解评价标准对预后的价值,并记录三个系恢复标准各自独立贡献。

研究设计与样本

  • 丹麦全国急性白血病登记研究,纳入769例诱导后骨髓原始细胞<5%的经典完全缓解患者。

主要发现

  • sCR患者360例(46.8%),non-SCR患者409例(53.2%)。
  • 校正协变量后,sCR患者总生存优于non-SCR(HR 1.34;95%CI 1.10-1.64)。
  • 校正协变量后,sCR患者无复发生存优于non-SCR(HR 1.25;95%CI 1.03-1.51)。
  • Cox回归分析显示三个系恢复标准均为显著且独立的变量。

关键数值与推荐

  • sCR定义为治疗后造血正常;non-SCR包括血小板、中性粒细胞或红细胞恢复不足。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stringent complete remission (sCR) of acute myeloid leukemia is defined as normal hematopoiesis after therapy. Less sCR, including non-sCR, was introduced as insufficient blood platelet, neutrophil, or erythrocyte recovery. These latter characteristics were defined retrospectively as postremission transfusion dependency and were suggested to be of prognostic value. In the present report, we evaluated the prognostic impact of achieving sCR and non-sCR in the Danish National Acute Leukaemia Registry, including 769 patients registered with classical CR (ie, <5% blasts in the postinduction bone marrow analysis). Individual patients were classified as having sCR (n = 360; 46.8%) or non-sCR (n = 409; 53.2%) based on data from our national laboratory and transfusion databases. Survival analysis revealed that patients achieving sCR had superior overall survival (hazard ratio [HR], 1.34; 95% confidence interval [CI], 1.10-1.64) as well as relapse-free survival (HR, 1.25; 95% CI, 1.03-1.51) compared with those with non-sCR after adjusting for covariates. Cox regression analysis regarding the impact of the stringent criteria for blood cell recovery identified these as significant and independent variables. In conclusion, this real-life register study supports the international criteria for response evaluation on prognosis and, most importantly, documents each of the 3 lineage recovery criteria as contributing independently.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Øvlisen AK, Oest A, Bendtsen MD, et al. Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia: a Danish population-based study. Blood Adv. 2018. PMID: 29523528. doi:10.1182/bloodadvances.2017007393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。